Abstract
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors. Among many other capabilities such as migration or immune escape, CTCs require tumor-forming capacities and can therefore be considered stem cell-like cells. This chapter describes the enrichment and isolation of live CTCs from clinical blood samples for molecular characterization and other downstream applications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30
Steinert G, Schölch S, Koch M et al (2012) Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg 397:535–542
Weitz J, Koch M, Debus J et al (2005) Colorectal cancer. Lancet 365:153–165
Pantel K, Alix-Panabières C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6:339–351
Schölch S, Bork U, Rahbari NN et al (2014) Circulating tumor cells of colorectal cancer. Cancer Cell Microenviron 1:10–14800
Rahbari NN, Bork U, Kircher A et al (2012) Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol 19:2195–2202
Rahbari NN, Aigner M, Thorlund K et al (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138:1714–1726
Bork U, Rahbari NN, Schölch S et al (2015) Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer 112:1306–1313
Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897–6904
Miller MC, Doyle GV, Terstappen LWMM (2010) Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010:617421
Chang YS, di Tomaso E, McDonald DM et al (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 97:14608–14613
Alix-Panabières C, Pantel K (2014) Technologies for detection of circulating tumor cells: facts and vision. Lab Chip 14:57–62
Steinert G, Schölch S, Niemietz T et al (2014) Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res 74:1694–1704
Schölch S, García SA, Iwata N et al (2016) Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer. Oncotarget 7:27232–27242
van Noort V, Schölch S, Iskar M et al (2014) Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling. Cancer Res 74:5690–5699
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
García, S.A., Weitz, J., Schölch, S. (2018). Circulating Tumor Cells. In: Papaccio, G., Desiderio, V. (eds) Cancer Stem Cells. Methods in Molecular Biology, vol 1692. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7401-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7401-6_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7400-9
Online ISBN: 978-1-4939-7401-6
eBook Packages: Springer Protocols